Get Started

RGBPP

OQB REGEN BIOPHARMA PFD A
Oct 30, 2026 · 2:38 AM ET EOD Market Closed

$0.0020 ↑ +0.0004 (+25.81%) Trading Up from the previous close of $0.0016, and at the day’s high of $0.0020

YTD change
-94.53%
vs 20-day SMA
+19.49%
vs 200-day SMA
-74.89%

Price ranges

Previous day
$0.0011 $0.0016
open $0.0011 close $0.0016
+$0.0004 (+39.64%)
Today
$0.0015 $0.0020
open $0.0015 now $0.0020
+$0.0005 (+30.00%)
Past week
$0.0008 $0.0023
from $0.0017 now $0.0020
+$0.0003 (+14.71%)
Past month
$0.0008 $0.0039
from $0.0029 now $0.0020
-$0.0010 (-33.67%)
This year
$0.0008 $0.0599
from $0.0356 now $0.0020
-$0.0337 (-94.53%)

Price & Performance

-0.00 (-37.50%) / 6M

$0.0004$0.0027$0.0049$0.0072Apr 29Jul 29Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.8% away from all-time highs of $0.8909
  • RGBPP is down 95% since the beginning of the year
  • RGBPP is down 99% over the past 12 months
  • RGBPP is down 34% over the past 1 month

RGBPP reads neutral: price sits above one of the two key moving averages, the 12-month move is -98.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-70
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeOQB
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap N/A

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,373.70 +6.63%
JNJ Johnson & Johnson $275.20 +1.53%
ABBV AbbVie, Inc. $290.79 +1.68%
MRK Merck & Co., Inc. $146.33 +3.83%
RHHVF Roche Holding Ltd $487.35 -0.04%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.